Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

FDA Warns Apotex Management To Demand Quality, Meet Specs

Aug 17 2018

• By Bowman Cox

Vintage inscription made by old typewriter, warning

Related Content

Manufacturing Compliance Updates In Brief: A Reduced Focus On Data Integrity

Apr 06 2018

FDA Resumes Quality Metrics Effort With Feedback And Site Visit Initiatives

Jun 28 2018

Manufacturing Compliance Updates In Brief From US FDA And EU

Jun 30 2018

The Baxter/Claris Warning Letter: Out Of Spec, Out Of Mind

Jul 24 2018

Fresenius Kabi Hit With Two Warning Letters At Sites In India In December

Jan 03 2018

FDA Cites Lupin For Poor Quality Metric Performance

Jun 30 2017

FDA’s Revised Quality Metrics Program: Voluntary Now, Mandatory Later

Nov 28 2016

Related Companies

Apotex Inc.

Additional Topics

United States India Asia Pacific Manufacturing Quality Compliance BioPharmaceutical

More from Manufacturing

More from Compliance

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window